Posted inEditorials, Opinion

Biopharmaceutical industry exceeded our wildest expectations

[et_pb_section fb_built=”1″ _builder_version=”4.4.8″][et_pb_row _builder_version=”4.4.8″][et_pb_column type=”4_4″ _builder_version=”4.4.8″][et_pb_text admin_label=”Biopharmaceutical industry exceeded our wildest expectations” _builder_version=”4.9.4″] Less than a year after the pandemic began, Americans had access to three highly effective vaccines that are paving the way forward and away from COVID-19, and that number could soon rise, as the FDA considers promising candidates from AstraZeneca and Novavax. […]

Gift this article